Minimally invasive sacroiliac joint fusion: Primary endpoint results from the prospective, multicenter STACI study

作者
Jacqueline S. Weisbein,Timothy T. Davis,Douglas P. Beall,Jack Smith,Caroline Harstroem,Daniel R. Kloster,Morteza Rabii,Robyn A. Capobianco,Ramana Naidu,Michael E Harned,Christopher A. Mallard,the STACI investigators
出处
期刊:Pm&r [Wiley]
卷期号:18 (9): 986-996 被引量:1
标识
DOI:10.1002/pmrj.70095
摘要

BACKGROUND: Chronic sacroiliac joint (SIJ) pain is highly debilitating. Minimally invasive SIJ fusion has become a commonly performed surgical treatment for SIJ pain, with level I evidence showing clinically significant improvements in pain, function, and quality of life and a low adverse event rate. Primarily performed by surgeons, this procedure is increasingly being performed by interventional pain management (IPM) physicians. PURPOSE: To evaluate the safety and effectiveness of lateral SIJ fusion performed by IPM physicians, compared with prior studies of similar devices. STUDY DESIGN: Prospective, multicenter, single-arm clinical trial conducted at 15 U.S. sites. PATIENT SAMPLE: A total of 112 patients with a diagnosis of SIJ pain, who met study eligibility criteria, underwent lateral SIJ fusion. OUTCOME MEASURES: SIJ pain (numerical rating scale [NRS]), Oswestry Disability Index (ODI), quality of life (Patient-Reported Outcomes Measurement Information System [PROMIS]-29), patient satisfaction, and device/procedure-related adverse events. METHODS: Medical and surgical history and patient-reported outcomes were assessed at baseline and follow-up at 1, 3, 6, 12, and 24 months postoperatively. Primary endpoint is change in SIJ pain from baseline to 6 months; statistical evaluation used a noninferiority approach with a 1-point noninferiority margin compared to prior studies of a similar device. Secondary endpoints included ODI, NRS, PROMIS-29, device/procedure-related adverse events, and evidence of fusion via computed tomography scan at 2 years. Twelve- and 24-month follow-up data collection is ongoing. RESULTS: Mean (SD) participant age was 64 (14) years and 68% female. No serious or device-related adverse events occurred. At 6 months, mean SIJ pain decreased 5.2 points (95% confidence interval [CI] 4.7-5.7), meeting the study's primary noninferiority endpoint (p < .001 for noninferiority, p < .001 for change from baseline). A majority (91%) had a ≥2-point improvement in SIJ pain. ODI improved by 25.8 points (95% CI 22.2-29.4, p < .001 vs. baseline). CONCLUSION: Interim trial results support the safety and effectiveness of lateral SIJ fusion performed by IPM physicians. Clinically significant improvements in pain and disability are commensurate with results from surgeon-performed randomized trials and published literature. Results should be reproduced in randomized trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
啊哒吸哇完成签到,获得积分0
2秒前
cly完成签到 ,获得积分10
2秒前
小胖子完成签到 ,获得积分10
3秒前
合适的绿柏完成签到,获得积分10
3秒前
aberner完成签到 ,获得积分10
4秒前
Hello的应助被369ninja采纳,获得30
4秒前
大大怪完成签到,获得积分10
10秒前
12秒前
飞哥与小佛完成签到,获得积分10
13秒前
乐乐的应助被王勾勾采纳,获得10
13秒前
macrossfev完成签到,获得积分10
13秒前
活泼雪莲发布了新的文献求助10
18秒前
save完成签到,获得积分10
19秒前
柠檬普洱茶完成签到,获得积分10
25秒前
安静怜雪完成签到,获得积分10
27秒前
Cosmosurfer完成签到,获得积分0
29秒前
观澜完成签到 ,获得积分10
29秒前
mousfy完成签到 ,获得积分10
32秒前
科研界的小白完成签到 ,获得积分10
32秒前
在水一方的应助被369ninja采纳,获得10
34秒前
任某人完成签到 ,获得积分10
35秒前
peterlaa3完成签到,获得积分10
35秒前
恬恬完成签到 ,获得积分10
36秒前
hamburger完成签到 ,获得积分10
36秒前
seawolf168完成签到,获得积分10
37秒前
种子完成签到,获得积分10
39秒前
meow完成签到 ,获得积分10
39秒前
sci完成签到 ,获得积分10
40秒前
jeronimo完成签到,获得积分10
42秒前
Az完成签到 ,获得积分10
43秒前
健忘语梦完成签到 ,获得积分10
45秒前
冯小晴完成签到 ,获得积分10
46秒前
chilit完成签到 ,获得积分10
47秒前
fxy完成签到 ,获得积分10
48秒前
泥猴桃完成签到,获得积分10
53秒前
白昼完成签到 ,获得积分10
53秒前
53秒前
小马甲的应助被活泼雪莲采纳,获得10
55秒前
如意大神完成签到,获得积分10
55秒前
麻衣少年完成签到 ,获得积分10
56秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166550
求助须知:如何正确求助?哪些是违规求助? 9559535
关于积分的说明 21750720
捐赠科研通 7757357
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553523
邀请新用户注册赠送积分活动 2473904